<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
XOMA
Xoma
$
()


  • Xoma announces closing of tender offer

    4/3/2024 - 09:14am
  • Xoma files $200M mixed securities shelf

    3/8/2024 - 16:38pm
  • Xoma reports 2023 EPS ($4.04) vs. ($1.98) last year

    3/8/2024 - 07:35am
  • Kinnate Biopharma price target raised by $1.09 at Stifel, here's why

    2/26/2024 - 07:40am
  • Xoma acquisition boosts royalty growth potential, says H.C. Wainwright

    2/16/2024 - 11:25am
  • Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR

    2/16/2024 - 08:05am
  • Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR

    2/16/2024 - 08:03am
  • Xoma expands commercial royalty, milestone portfolio with DSUVIA acquisition

    1/18/2024 - 08:35am
  • Xoma to make $1M payment to LadRx after FDA acceptance of arimoclomol NDA

    1/11/2024 - 16:12pm
  • Xoma appoints Owen Hughes as CEO, Jack Wyszomierski as chairman

    1/8/2024 - 07:53am
  • Xoma board authorizes $50M stock repurchase program

    1/2/2024 - 07:32am
  • Xoma raises up to $140M in non-recourse financing

    12/19/2023 - 07:40am
  • Fly Insider: Emerson, Frontdoor among week's notable insider trades

    11/13/2023 - 15:28pm
  • Xoma reports Q3 EPS (60c) vs (48c) last year

    11/7/2023 - 07:34am
  • Xoma earns $5M milestone upon FDA acceptance of Day One's tovorafenib NDA

    10/31/2023 - 07:37am
dynamic_feed Breaking News